Nykode Therapeutics AS (OSL:NYKD)

Nykode Therapeutics AS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	69.99	115.4	162.6	206.39	216.23	183.85
Trading Asset Securities	-	-	-	-	12.17	24.94
Cash & Short-Term Investments	69.99	115.4	162.6	206.39	228.4	208.8
Cash Growth	-48.74%	-29.03%	-21.21%	-9.64%	9.39%	555.64%
Accounts Receivable	-	-	-	2.54	23.75	18.75
Other Receivables	2.77	0.91	1.07	1.79	2.41	1.34
Receivables	2.77	0.91	1.07	4.33	26.16	20.09
Prepaid Expenses	-	0.76	2.01	1.15	1.3	0.15
Other Current Assets	-	-	-	-	-	-0
Total Current Assets	72.75	117.07	165.68	211.87	255.86	229.03
Property, Plant & Equipment	6.63	7.74	10.52	9.53	9.17	0.41
Other Intangible Assets	0.07	0.07	0.07	0.03	0.03	0.03
Long-Term Deferred Charges	-	-	-	-	0.48	0.55
Other Long-Term Assets	32.16	28.6	31.92	0.05	0.02	0.01
Total Assets	111.61	153.48	208.19	221.48	265.56	230.03
Accounts Payable	2.96	0.86	1.33	2.31	2.75	1.61
Accrued Expenses	-	3.62	6.08	7.58	9.3	9.68
Current Portion of Leases	1.26	1.29	1.46	1.15	1.35	0.28
Current Income Taxes Payable	0.02	0.02	-	0.08	0.03	-
Current Unearned Revenue	-	-	8.34	19.87	16.26	-
Other Current Liabilities	0.54	3.3	3.41	8	1.69	1.61
Total Current Liabilities	4.78	9.1	20.61	38.99	31.37	13.18
Long-Term Leases	1.84	2.15	4.27	4.37	5.82	0.01
Long-Term Deferred Tax Liabilities	1.3	5.2	12.05	21.08	29.4	31.13
Other Long-Term Liabilities	0.93	0.82	0	0.03	4.91	6.86
Total Liabilities	8.84	17.27	36.93	64.46	71.5	51.18
Common Stock	0.37	0.37	0.37	0.34	0.33	0.33
Additional Paid-In Capital	96.71	128.99	128.99	83.32	81.53	60.35
Retained Earnings	-9.53	-8.76	29.56	64.71	107.46	116.87
Comprehensive Income & Other	15.22	15.62	12.35	8.65	4.74	1.31
Shareholders' Equity	102.77	136.21	171.26	157.02	194.06	178.85
Total Liabilities & Equity	111.61	153.48	208.19	221.48	265.56	230.03
Total Debt	3.1	3.44	5.73	5.51	7.17	0.28
Net Cash (Debt)	66.89	111.96	156.88	200.87	221.23	208.51
Net Cash Growth	-49.23%	-28.63%	-21.90%	-9.20%	6.10%	556.60%
Net Cash Per Share	0.20	0.34	0.52	0.69	0.77	0.70
Filing Date Shares Outstanding	326.55	326.55	326.55	294.69	289.62	284.79
Total Common Shares Outstanding	326.55	326.55	326.55	294.69	289.62	284.79
Working Capital	67.97	107.97	145.07	172.89	224.49	215.85
Book Value Per Share	0.31	0.42	0.52	0.53	0.67	0.63
Tangible Book Value	102.7	136.14	171.19	156.99	194.02	178.82
Tangible Book Value Per Share	0.31	0.42	0.52	0.53	0.67	0.63
Machinery	-	5.02	4.97	3.44	1.46	0.2

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.